Adult consultation by oncologist (gynaecologist), expert of the sector in the clinic
Follow-up consultation by obstetrician-gynaecologist, expert of the sector (on the results of additional examination within 10 days)
Cobas HPV test, FDA-approved, 14 types of HPV VCF: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68 types (with genotyping of types 16 and 18)
Liquid Cytology CellPrep PAP test
Bacteriological examination of urogenital discharge
Quantitative culture for mycoplasma/ureaplasma (DUO)
Sampling for PCR-based diagnostics
Determination of Candida albicans in biological material (PCR method)
Determination of Gardnerella vaginalis in biological material (PCR method)
Determination of Mycoplasma genitalis in biological material (PCR method)
Determination of Neisseria gonorrheae in biological material (PCR method)
Determination of Trichomonas vaginalis in biological material (PCR method)
Histological examination after endometrial biopsy (aspiration biopsy, curettage, polypectomy)
Histological examination after cervical biopsy (non-excisional)
Histological examination after curettage of the cervical canal, polypectomy
Histological examination after excision and conization of the cervix
Examination of the microflora of the urogenital tract in women (according to the Hay-Ison criteria and the Nugent scale)
Incisional biopsy of the 3rd category
Complex genotyping of HPV DNA (28 genotypes) in a semi-quantitative form REAL TIME
Screening for 7 STD (detection of Trichomonas vaginalis, Chlamydia trachomatis, Mycoplasma hominis, Mycoplasma genitalium, Neisseria gonorrhoeae, Ureaplasma urealyticum, Ureaplasma parvum using PCR method) - semiquantitative
Quantification of Ureaplasma urealiticum in biological material (PCR method)
Incisional biopsy of the 1st category
Incisional biopsy of the 2nd category